Klinische Studien zur Verbesserung der Prognose von Postinfarktpatienten mittels antiarrhythmischer Therapie
Reference22 articles.
1. Bastian BC, Macfarlane P W, McLauchlan JH, Ballantyne D, Clark R, Hillis WS, Rae AP, Hutton I (1980) A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J 100: 1017–1022
2. Bennett MA, Wilner JM, Pentecost BL (1970) Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet 2: 909–911
3. Chamberlain DA, Jewitt DE, Julian DG, Campbell RWF, Boyle DMcC, Shanks RG (1980) Oral mexiletine in high risk patients after myocardial infarction. Lancet 2: 1324–1327
4. Collaborative group (1971) Phenytoin after recovery from myocardial infarction. Controlled trial in 568 patients. Lancet 2: 1055–1057
5. Darby S, Bennett MA, Cruickshank JC, Pentecost BL (1972) Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet 1: 817–819